Yasunori Kasahara
Overview
Explore the profile of Yasunori Kasahara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
1017
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aoki A, Iwamura C, Kiuchi M, Tsuji K, Sasaki A, Hishiya T, et al.
J Clin Immunol
. 2024 Apr;
44(4):104.
PMID: 38647550
Purpose: Auto-antibodies (auto-abs) to type I interferons (IFNs) have been identified in patients with life-threatening coronavirus disease 2019 (COVID-19), suggesting that the presence of auto-abs may be a risk factor...
2.
Iwamura C, Hirahara K, Kiuchi M, Ikehara S, Azuma K, Shimada T, et al.
Proc Natl Acad Sci U S A
. 2022 Jul;
119(33):e2203437119.
PMID: 35895716
The mortality of coronavirus disease 2019 (COVID-19) is strongly correlated with pulmonary vascular pathology accompanied by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-triggered immune dysregulation and aberrant activation of...
3.
Ikubo Y, Kasai H, Sugiura T, Saito T, Shoji H, Sakao S, et al.
Intern Med
. 2019 Feb;
58(12):1765-1769.
PMID: 30799344
Hepatopulmonary syndrome (HPS) and pulmonary arteriovenous malformation (PAVM) are hypoxemic diseases caused by right-to-left shunting but are rarely concomitant with pulmonary hypertension (PH). A 66-year-old woman with chronic hepatitis C...
4.
Sakurai-Iesato Y, Kawata N, Tada Y, Iesato K, Matsuura Y, Yahaba M, et al.
Intern Med
. 2017 Jul;
56(14):1781-1790.
PMID: 28717072
Objective Osteoporosis, which is now recognized as a major comorbidity of chronic obstructive pulmonary disease (COPD), must be diagnosed by appropriate methods. The aims of this study were to clarify...
5.
Tokura S, Akira M, Okuma T, Tazawa R, Arai T, Sugimoto C, et al.
Ann Am Thorac Soc
. 2017 May;
14(9):1403-1411.
PMID: 28489417
Rationale: A useful semiquantitative method of using computed tomographic (CT) images to evaluate therapeutic response in pulmonary alveolar proteinosis (PAP) has not been established, although the extent score or grading...
6.
Takayanagi S, Kawata N, Tada Y, Ikari J, Matsuura Y, Matsuoka S, et al.
Int J Chron Obstruct Pulmon Dis
. 2017 Mar;
12:551-560.
PMID: 28243075
Background: Recent advances in multidetector computed tomography (MDCT) facilitate acquiring important clinical information for managing patients with COPD. MDCT can detect the loss of lung tissue associated with emphysema as...
7.
Urushibara T, Tanabe N, Suda R, Kato F, Kasai H, Takeuchi T, et al.
Circ J
. 2015 Oct;
79(12):2696-702.
PMID: 26467079
Background: This study aimed to investigate the predictors of quality of life (QOL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH), changes in QOL after surgical and medical treatments, and...
8.
Suzuki T, Tada Y, Kawata N, Ikari J, Kasahara Y, Sakurai Y, et al.
Int J Chron Obstruct Pulmon Dis
. 2015 Jul;
10:1199-205.
PMID: 26150711
Background: The COPD assessment test (CAT) score is a key component of the multifactorial assessment of COPD in the Global initiative for chronic Obstructive Lung Disease (GOLD) guidelines of 2014....
9.
Suzuki T, Tada Y, Tsushima K, Terada J, Sakurai T, Watanabe A, et al.
Respir Med Case Rep
. 2015 Jun;
10:27-30.
PMID: 26029507
A 66-year-old male treated with everolimus for renal cell carcinoma developed exertional dyspnea. Chest computed tomography revealed diffuse interstitial shadows on both lungs. Bronchoalveolar lavage and the drug-induced lymphocyte stimulation...
10.
Suzuki T, Tada Y, Kawata N, Matsuura Y, Ikari J, Kasahara Y, et al.
Int J Chron Obstruct Pulmon Dis
. 2015 Jun;
10:947-54.
PMID: 26028967
Background: Asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is associated with rapid decline in lung function, poorer health-related quality-of-life outcomes, and frequent exacerbations, compared to COPD alone. Although the...